Thailand is the first country to approve the manufacture of the Covid nasal spray

0

Thailand is the first country to approve the manufacture of the Covid nasal spray

“We are very proud to have shared our knowledge with healthcare companies that have leveraged the evidence-based research we have conducted. It’s great to see that such collaboration has led to the development of a product,” says Dr. Chanchai.

A team of researchers from the Faculty have been working on the development of the spray since the start of the pandemic two years ago, the team then discovered the antibody used in the prototype and patented it.

He explains that the antibody-based nasal spray was developed as part of a research project on a cocktail of monoclonal antibodies obtained from Covid-19 patients who have fully recovered. It has been shown to be able to inhibit Covid-19 infections.

Monoclonal antibodies are a powerful tool in clinical research with applications in many fields, including biotechnology.

Thailand is the first country to approve the manufacture of the Covid nasal spray

Stay up to world-class quality standards
Dr Withoon Danwiboon says his organization has supported the ministry’s work by producing, supplying, reserving and distributing medicines, medical supplies and protective tools for use in the country during the health crisis.

In addition, the organization has endeavored to promote the local pharmaceutical industry in the use of medical innovations for the production of quality medicines and tools and supports the research and development of pharmaceuticals and medical supplies.

“We are delighted to have been selected as the manufacturer of this ‘antibody-based nasal spray’,” says Dr Withoon, adding that the nasal spray has been registered and approved by the Thai FDA.

Thailand is the first country to approve the manufacture of the Covid nasal spray
A promising nasal spray
Worrawan says the spray is now available in the market. She notes that the spray can be effective in suppressing coronavirus infections, citing a clinical trial that showed the spray can reduce infection with SARS-CoV-2, the virus that effectively causes Covid-19. It can provide around 6 hours of protection with just two sprays per nostril. The antibody-based nasal spray could prevent the coronavirus from infecting the body by trapping the virus that enters the nose and neutralizing it or weakening it, making it unable to cause infection inside the body.

Share.

Comments are closed.